ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Roche names Aviv Regev head of research

by Michael McCoy
May 15, 2020 | APPEARED IN VOLUME 98, ISSUE 19

 

09819-buscon14-regev.jpg
Credit: Roche
Aviv Regev

Aviv Regev will become head of research and early development at Roche’s Genentech unit on Aug. 1. She will replace Michael Varney, an organic chemist who is retiring after 15 years with Genentech. Regev, a computational biologist, has posts at the Massachusetts Institute of Technology, the Broad Institute of MIT and Harvard, and the Howard Hughes Medical Institute.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment